These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

725 related items for PubMed ID: 12209139

  • 1. Antibodies, viruses and vaccines.
    Burton DR.
    Nat Rev Immunol; 2002 Sep; 2(9):706-13. PubMed ID: 12209139
    [Abstract] [Full Text] [Related]

  • 2. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H, Minke JM, Rehder J, Richard S, Edlund Toulemonde C, Dinic S, Andreoni C, Audonnet JC, Nordgren R, Juillard V.
    Vet Immunol Immunopathol; 2008 Jun 15; 123(3-4):230-9. PubMed ID: 18372050
    [Abstract] [Full Text] [Related]

  • 3. Immunological memory to viral infection.
    Slifka MK.
    Curr Opin Immunol; 2004 Aug 15; 16(4):443-50. PubMed ID: 15245737
    [Abstract] [Full Text] [Related]

  • 4. Viral strategies for evading antiviral cellular immune responses of the host.
    Iannello A, Debbeche O, Martin E, Attalah LH, Samarani S, Ahmad A.
    J Leukoc Biol; 2006 Jan 15; 79(1):16-35. PubMed ID: 16204622
    [Abstract] [Full Text] [Related]

  • 5. [Current vaccination strategies].
    Dietz K.
    Internist (Berl); 1992 Sep 15; 33(9):575-80. PubMed ID: 1399392
    [No Abstract] [Full Text] [Related]

  • 6. Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice.
    Konishi E, Kosugi S, Imoto J.
    Vaccine; 2006 Mar 15; 24(12):2200-7. PubMed ID: 16316713
    [Abstract] [Full Text] [Related]

  • 7. Antibody-mediated protection against respiratory viral infection.
    Dubois ME, Yoshihara P, Slifka MK.
    Semin Respir Crit Care Med; 2005 Dec 15; 26(6):635-42. PubMed ID: 16388432
    [Abstract] [Full Text] [Related]

  • 8. Why vaccines are not the answer - the failure of V520 and the importance of cell-mediated immunity in the fight against HIV.
    White A.
    Med Hypotheses; 2008 Dec 15; 71(6):909-13. PubMed ID: 18768264
    [Abstract] [Full Text] [Related]

  • 9. Antibodies and B cell memory in viral immunity.
    Dörner T, Radbruch A.
    Immunity; 2007 Sep 15; 27(3):384-92. PubMed ID: 17892847
    [Abstract] [Full Text] [Related]

  • 10. The role of neutralizing antibodies in HIV infection.
    Humbert M, Dietrich U.
    AIDS Rev; 2006 Sep 15; 8(2):51-9. PubMed ID: 16848273
    [Abstract] [Full Text] [Related]

  • 11. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.
    Pantaleo G, Koup RA.
    Nat Med; 2004 Aug 15; 10(8):806-10. PubMed ID: 15286782
    [Abstract] [Full Text] [Related]

  • 12. Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.
    Haynes BF, Montefiori DC.
    Expert Rev Vaccines; 2006 Aug 15; 5(4):579-95. PubMed ID: 16989638
    [Abstract] [Full Text] [Related]

  • 13. AIDS vaccine development: the long and winding road.
    Garber DA, Feinberg MB.
    AIDS Rev; 2003 Aug 15; 5(3):131-9. PubMed ID: 14598562
    [Abstract] [Full Text] [Related]

  • 14. Translating antibody insights.
    Gerberding JL.
    Science; 2013 Sep 13; 341(6151):1151. PubMed ID: 24030986
    [No Abstract] [Full Text] [Related]

  • 15. Strategies in therapy and immunoprophylaxis of human immunodeficiency virus infection.
    Ferdinand FJ.
    Arzneimittelforschung; 1990 Jan 13; 40(1):106-10. PubMed ID: 2187439
    [Abstract] [Full Text] [Related]

  • 16. Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments.
    Hone DM, DeVico AL, Fouts TR, Onyabe DY, Agwale SM, Wambebe CO, Blattner WA, Gallo RC, Lewis GK.
    J Hum Virol; 2002 Jan 13; 5(1):17-23. PubMed ID: 12352264
    [Abstract] [Full Text] [Related]

  • 17. Fc receptor but not complement binding is important in antibody protection against HIV.
    Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci G, Forthal DN, Parren PW, Marx PA, Burton DR.
    Nature; 2007 Sep 06; 449(7158):101-4. PubMed ID: 17805298
    [Abstract] [Full Text] [Related]

  • 18. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications.
    Takada A, Kawaoka Y.
    Rev Med Virol; 2003 Sep 06; 13(6):387-98. PubMed ID: 14625886
    [Abstract] [Full Text] [Related]

  • 19. Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity.
    VanBlargan LA, Goo L, Pierson TC.
    Microbiol Mol Biol Rev; 2016 Dec 06; 80(4):989-1010. PubMed ID: 27784796
    [Abstract] [Full Text] [Related]

  • 20. The role of particle-mediated DNA vaccines in biodefense preparedness.
    Dean HJ, Haynes J, Schmaljohn C.
    Adv Drug Deliv Rev; 2005 Jun 17; 57(9):1315-42. PubMed ID: 15935876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.